Emylcamate(marketed asStriatranbyMerck) is ananxiolyticandmuscle relaxant.It was patented in the US in 1961 (US Patent 2,972,564) and advertised for the treatment of anxiety and tension. It was claimed to be superior tomeprobamate,which would eventually replace emylcamate.
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.001.002 |
| Chemical and physical data | |
| Formula | C7H15NO2 |
| Molar mass | 145.202g·mol−1 |
| 3D model (JSmol) | |
| |
| |
A study of the drug's effects in mice was done in 1959. It concluded that at 50 mg/kg emylcamate gave a 63% decrease in motor activity compared with meprobamate's 32% decrease, a doubling in effective potency. The therapeutic index in mice was also established:
| Meprobamate | Emylcamate | Effect |
|---|---|---|
| 175 | 123 | ED50(mg/kg) |
| 600 | 550 | LD50(mg/kg) |
| 3.4 | 4.4 | Therapeutic index |
Emylcamate also has a faster intra-parenteral onset than meprobamate, 3 minutes compared with 35.[2]
Synthesis
editEmylcamate is thecarbamateof thetertiary alcohol3-methyl-3-pentanol. The first patented synthesis involved treating that alcohol withpotassium cyanateandtrichloroacetic acid.[3]In 1963, an improved synthesis was reported using sodium cyanate and trifluoroacetic acid.[4]
References
edit- ^Anvisa(2023-03-31)."RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial"[Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese).Diário Oficial da União(published 2023-04-04).Archivedfrom the original on 2023-08-03.Retrieved2023-08-16.
- ^Melander B (1959). "Emylcamate, A Potent Tranquillizing Relaxant".Journal of Medicinal and Pharmaceutical Chemistry.1(5):443–457.doi:10.1021/jm50006a003.
- ^US patent 2972564,Melander BO, Hanshoff G, "3-Methyl-3-pentanol carbamate compositions having muscle relaxing and tranquilizing action", issued 1961-02-21, assigned to Phadia AB
- ^Loev B, Kormendy MF (1963). "An Improved Synthesis of Carbamates".The Journal of Organic Chemistry.28(12):3421–3426.doi:10.1021/jo01047a033.
Further reading
edit- Shorter E (August 2004)."Olhando para trás: um novo caminho possível para a descoberta de drogas em psicofarmacologia"[Looking back: a new possible path for drug discovery in psychopharmacology.].Revista de Psiquiatria do Rio Grande do Sul(in Portuguese).26(2):196–203.doi:10.1590/S0101-81082004000200009.
External links
edit- "Emylcamate".The Comparative Toxicogenomics Database.
- "Emylcamate".BIAM(in French). Archived fromthe originalon 2022-09-26.Retrieved2005-12-22.
 | Thisdrugarticle relating to themusculoskeletal systemis astub.You can help Wikipedia byexpanding it. |
 | This article about ananxiolyticis astub.You can help Wikipedia byexpanding it. |